APTech "Momstamin Containing Human Milk Oligosaccharides Enters Amazon... Targeting Global Market"

[Asia Economy Reporter Hyunseok Yoo] AP Technology, a company specializing in Human Milk Oligosaccharides (HMO), announced on the 25th that it has entered the world's largest e-commerce platform, Amazon, to showcase 'Momstamin.' Starting with Amazon in the United States, the company plans to expand into various e-commerce platforms to target the global market for 'Momstamin.'

Momstamin is a global health functional food brand based on 2’-FL, a key component of Human Milk Oligosaccharides (HMO). HMOs are representative components found in high concentrations in breast milk, performing functions such as forming a healthy gut microbiome, expelling harmful bacteria and viruses, activating immunity, and promoting the growth and protection of brain cells.

The first product of Momstamin contains Human Milk Oligosaccharides (HMO), probiotics including Bifidobacteria, vitamins, and minerals, aimed at gut health and immune activation. HMOs are known to have positive interactions by inducing the proliferation and colonization of beneficial gut microorganisms such as Bifidobacteria.

An AP Technology official stated, “Entering Amazon is the result of about 20 years of dedication to developing manufacturing processes for Human Milk Oligosaccharides and recognition of our technological capabilities in the industry.” He added, “As the benefits of HMOs are emphasized worldwide and the related industry is rapidly growing, we will strive to secure a leading position in this market.”

Established in 2001, AP Technology developed HMO production technology using an internationally patented bio-process. The company completed an HMO production plant in Hwaseong, Gyeonggi Province, with an annual capacity of 100 tons and plans to expand both domestically and internationally. In February, it obtained GRAS (Generally Recognized As Safe) certification from the U.S. Food and Drug Administration (FDA), a rigorous safety raw material certification system, and in April, it was also approved as a food ingredient by the Korean Ministry of Food and Drug Safety.

The company emphasized, “We will expand our sales portfolio by utilizing 2’-FL, which can be applied to various products such as functional foods, cosmetics, and daily necessities,” and added, “We plan to enter the brain health and blood circulation improvement treatment markets in the future.”

This content was produced with the assistance of AI translation services.